Streetbeat News

Regulatory

ANVS

Annovis Bio (NYSE: ANVS) receives a positive safety review from the Data and Safety Monitoring Board (DSMB) for its phase III trial of buntanetap, a drug for early Parkinson's Disease patients. The trial enrolled 523 patients in nine months, with a low dropout rate of 6%. Topline results are expected by the end of 2023.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 4:06 pm

SPY

The U.S. Senate Banking Committee is set to deliberate on the RECOUP Act, which would grant regulators the power to seize executive compensation following bank failures. The bill is backed by Senate Banking Committee Chairman Sherrod Brown and Sen. Tim Scott and aims to increase regulatory authority and accountability.

Portfolio Pulse from Piero Cingari

June 20, 2023 | 4:05 pm

KBE

KRE

SPY

XLF

Fed's Barr emphasizes the importance of banks having a system that challenges risk decisions, which could impact the financial sector ETFs.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 3:58 pm

KBE

KRE

SPY

XLF

Fed's Williams states that improving banking culture is a 'long game' and notes progress in this area. Regulators worldwide are focusing on bank culture improvements.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 3:56 pm

NNOX

Nano-X Imaging has been granted European Patent Number EP2826056 for its X-ray emitting device, which could potentially strengthen the company's intellectual property portfolio.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 3:53 pm

PYPL

Regulatory concerns surrounding cryptocurrencies have negatively impacted American payment companies like PayPal and Stripe, causing a halt in innovation and allowing international competitors to take advantage. PayPal's stock (NASDAQ:PYPL) is down nearly 11% year-to-date.

Portfolio Pulse from Andrew Chapin

June 20, 2023 | 3:36 pm

INDA

MU

India's Cabinet has approved Micron Technology's $2.7 billion chip packaging and testing plant in Gujarat, according to a government source cited by Reuters.

Portfolio Pulse from Happy Mohamed

June 20, 2023 | 3:33 pm

PLUG

Plug Power Inc (NASDAQ:PLUG) shares are trading lower by 8.80% to $9.64 during Tuesday's session, possibly due to broader market trends and anticipation of Federal Reserve Chair Jerome Powell's testimony before Congress. Changes in interest rates can impact the clean energy sector and companies like Plug Power.

Portfolio Pulse from Henry Khederian

June 20, 2023 | 3:32 pm

GERN

Geron Corporation (NASDAQ:GERN) submitted a marketing application to the FDA for imetelstat, a treatment for transfusion-dependent anemia in adult patients with low- to intermediate-1 risk myelodysplastic syndromes. The submission is based on positive results from the IMerge Phase 3 trial. Geron has requested a Priority Review and plans to submit a European marketing application in 2H 2023.

Portfolio Pulse from Vandana Singh

June 20, 2023 | 3:32 pm